UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2015, Da lontano, ISBN 8882473694, Volume 6., 317
Book
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 265 - 266
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 425 - 439
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Piperazines - administration & dosage | Estradiol - analogs & derivatives | Pyridines - administration & dosage | Double-Blind Method | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Estradiol - administration & dosage | Treatment Outcome | Breast Neoplasms - drug therapy | Neoplasm Recurrence, Local - pathology | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Neoplasm Metastasis | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Breast Neoplasms - pathology | Adult | Female | Neoplasm Recurrence, Local - genetics | Aged | Mutation | Medical colleges | Care and treatment | Oncology, Experimental | Clinical trials | Breast cancer | Metastasis | Hormones | Research | Antineoplastic agents | Epidemiology | Antimitotic agents | Analysis | Product development | Cancer | Index Medicus
Journal Article
Nature reviews. Clinical oncology, ISSN 1759-4774, 11/2015, Volume 12, Issue 11, pp. 631 - 644
Life Sciences & Biomedicine | Oncology | Science & Technology | Female | Antineoplastic Agents - administration & dosage | Administration, Metronomic | Breast Neoplasms - drug therapy | Humans | Randomized Controlled Trials as Topic | Care and treatment | Chemotherapy | Breast cancer | Methods | Cancer | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 4, pp. 297 - 305
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Breast Neoplasms - surgery | Lymph Nodes - pathology | Follow-Up Studies | Lymph Nodes - surgery | Humans | Middle Aged | Treatment Outcome | Lymphatic Metastasis | Breast Neoplasms - physiopathology | Disease-Free Survival | Neoplasm Grading | Neoplasm Micrometastasis | Breast Neoplasms - pathology | Axilla | Adult | Female | Aged | Sentinel Lymph Node Biopsy | Surgery | Index Medicus
Journal Article
Cancer letters, ISSN 0304-3835, 2017, Volume 400, pp. 259 - 266
Hematology, Oncology and Palliative Medicine | Breast cancer | Metronomic chemotherapy | Immunomodulation | Triple negative | Neoadjuvant treatment | Adjuvant treatment | Life Sciences & Biomedicine | Oncology | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Administration, Metronomic | Humans | Immunologic Factors - administration & dosage | Treatment Outcome | Antineoplastic Agents - administration & dosage | Triple Negative Breast Neoplasms - drug therapy | Animals | Antineoplastic Agents - adverse effects | Neoadjuvant Therapy - adverse effects | Triple Negative Breast Neoplasms - pathology | Female | Chemotherapy, Adjuvant | Drug therapy | Analysis | Cancer | Index Medicus
Journal Article
12/2019, Volume 11, 10
Book Review
The New England journal of medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 20, pp. 1926 - 1936
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Piperazines - administration & dosage | Estradiol - analogs & derivatives | Pyridines - administration & dosage | Double-Blind Method | Humans | Middle Aged | Estradiol - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Protein Kinase Inhibitors - adverse effects | Breast Neoplasms - drug therapy | Piperazines - adverse effects | Fulvestrant | Protein Kinase Inhibitors - administration & dosage | Receptors, Steroid - analysis | Pyridines - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Estradiol - adverse effects | Breast Neoplasms - mortality | Female | Aged | ErbB Receptors - analysis | Cancer patients | Safety and security measures | Breast cancer | Dosage and administration | Drug therapy | Health aspects | Medical research | Statistical analysis | Cyclin-dependent kinases | Endocrine therapy | Metastasis | Cancer therapies | Survival | ErbB-2 protein | Cyclin-dependent kinase 4 | Metastases | Chemotherapy | Epidermal growth factor | Womens health | Medical prognosis | Mutation | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2019, Volume 381, Issue 4, pp. 307 - 316
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Aminopyridines - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Protein Kinase Inhibitors - adverse effects | Purines - administration & dosage | Tamoxifen - administration & dosage | Adult | Female | Perimenopause | Purines - adverse effects | Cyclin-Dependent Kinases - antagonists & inhibitors | Aromatase Inhibitors - administration & dosage | Aminopyridines - administration & dosage | Double-Blind Method | Premenopause | Receptors, Estrogen | Breast Neoplasms - drug therapy | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Receptors, Progesterone | Intention to Treat Analysis | Survival Analysis | Breast Neoplasms - mortality | Receptor, ErbB-2 | Cyclin-dependent kinases | Clinical trials | Endocrine therapy | Breast cancer | Metastasis | Tamoxifen | Patients | Cancer therapies | Survival | ErbB-2 protein | Cyclin-dependent kinase 4 | Chemotherapy | Epidermal growth factor | Womens health | Medical prognosis | Aromatase | Death | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 2, pp. 131 - 132
Journal Article